Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...

AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.

The US Food and Drug Administration (FDA) has granted approval for Roche's Gazyva/ Gazyvaro (obinutuzumab) to treat adult ...

Critics have warned that lowered hiring standards and slashed training times will lead to an explosion of abuses by immigration officers ...

The FDA has approved Gazyva (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

Some officials in President Donald Trump's administration are now starting to admit that the longer the federal government ...

Shriram Finance, Tech Mahindra, Titan Company, TCS, Tata Steel were among major gainers on the Nifty, while losers were Max Healthcare, Maruti Suzuki and Apollo Hospitals. BSE Midcap and smallcap ...

The American Hospital Association warned future tariffs arising from the Trump administration’s Section 232 investigation ...

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva ® (obinutuzumab) for the treatment of adult ...

Treasury Secretary Scott Bessent’s multibillion-dollar bailout of a serial defaulter raises the specter of losses for the ...